Weekly Vitamin D Dosing for Adults
For adults without renal impairment or hypercalcemia, the standard weekly dose of vitamin D3 (cholecalciferol) is 50,000 IU once weekly for 6-8 weeks to treat deficiency, followed by maintenance dosing of 1,500-2,000 IU daily (or equivalent weekly dosing). 1
Treatment Approach Based on Vitamin D Status
For Vitamin D Deficiency (25(OH)D < 20 ng/mL)
The Endocrine Society guideline 1 provides the most authoritative recommendation:
- 50,000 IU of vitamin D2 or D3 once weekly for 8 weeks to achieve 25(OH)D levels above 30 ng/mL
- Alternative: 6,000 IU daily for 8 weeks (equivalent total dose)
- After repletion, transition to maintenance: 1,500-2,000 IU daily
This is corroborated by multiple guidelines 2 that recommend 50,000 IU weekly for 8 weeks as the standard corrective regimen.
For Maintenance After Repletion
Once 25(OH)D levels reach ≥30 ng/mL:
- Daily dosing: 1,500-2,000 IU/day 1
- Weekly equivalent: Approximately 10,000-14,000 IU/week (based on the principle that weekly dosing of equivalent cumulative doses produces similar 25(OH)D levels) 2
For Prevention in At-Risk Adults
For adults ≥50 years requiring prophylaxis without documented deficiency:
- 800 IU daily or its intermittent equivalent 1, 2
- Weekly equivalent: approximately 5,600 IU/week
- Some guidelines suggest 100,000 IU every 3 months as an alternative intermittent regimen 2
Special Populations Requiring Higher Doses
Obese patients, those with malabsorption syndromes, or on medications affecting vitamin D metabolism (anticonvulsants, glucocorticoids, ketoconazole, AIDS medications) require 2-3 times higher doses 1:
- Treatment: 6,000-10,000 IU daily (or 42,000-70,000 IU weekly)
- Maintenance: 3,000-6,000 IU daily (or 21,000-42,000 IU weekly)
Critical Safety Considerations
Avoid Very High Intermittent Doses
Do not use annual high-dose regimens (e.g., 500,000 IU annually), as these have been associated with adverse outcomes including increased falls and fractures 2, 3. Daily, weekly, or monthly strategies are preferred over longer intervals.
Dosing Interval Matters
Evidence suggests that:
- Dosing intervals >12 weeks may increase fall risk 3
- Weekly or monthly dosing is safer than quarterly or annual boluses
- Doses >100,000 IU per administration may carry higher fracture risk 3
Monitoring Requirements
- Monitor serum calcium during treatment to prevent hypercalcemia 4, 1
- The development of hypercalcemia indicates excessive dosing 4
- Upper safety limit for 25(OH)D is approximately 100 ng/mL, though target range is 30-50 ng/mL 2
Practical Weekly Dosing Regimens
Based on the evidence, here are specific weekly protocols:
For documented deficiency:
- Week 1-8: 50,000 IU once weekly 1, 5
- After week 8: Transition to 10,000-14,000 IU weekly for maintenance
For insufficiency (20-30 ng/mL):
- 30,000 IU weekly for 8-12 weeks 6
- Then maintenance with 10,000 IU weekly
For prevention in normal-weight adults:
- 5,000-7,000 IU weekly 7
Vitamin D3 vs D2
Prefer vitamin D3 (cholecalciferol) over D2 (ergocalciferol) for intermittent dosing 2:
- D3 maintains serum 25(OH)D concentrations longer than D2 with intermittent regimens
- D3 has higher bioefficacy 4
- Both are acceptable for daily dosing, but D3 is superior for weekly/monthly schedules
Common Pitfalls to Avoid
Don't use active vitamin D analogs (calcitriol, alfacalcidol, doxercalciferol, paricalcitol) to treat nutritional vitamin D deficiency 4
Don't assume all patients need the same dose - obesity, malabsorption, and certain medications dramatically increase requirements 1, 6
Don't use mega-bolus dosing (>100,000 IU per dose or >quarterly intervals) outside of specific clinical scenarios 3
Don't supplement without considering contraindications - avoid in hypercalcemia, malabsorption syndrome, hypervitaminosis D, or granulomatous diseases (sarcoidosis) where unregulated extrarenal 1α-hydroxylase activity can cause severe hypercalcemia 8